Skip to content
healthcare.dev

buprenorphine hydrochloride and naloxone hydrochloride dihydrate

NDC 70518-3844, buprenorphine hydrochloride and naloxone hydrochloride dihydrate, tablet, from REMEDYREPACK INC..

Product NDC
70518-3844
Status
Listed
Labeler
REMEDYREPACK INC.
Dosage form
TABLET
Route
SUBLINGUAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203326
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70518-3844 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPRENORPHINE HYDROCHLORIDE8 mg/1
  • NALOXONE HYDROCHLORIDE DIHYDRATE2 mg/1

Pharmacologic classes

Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]

Package NDCNDC-11Package
70518-3844-07051838440030 TABLET in 1 BLISTER PACK (70518-3844-0)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4124c4ad-ef62-4c95-8e57-0d843862ae71

Use it

Look up 70518-3844 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70518-3844 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70518-3844. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.